Similar articles

• Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications.

  Iversen LL, Dourish CT, Iversen SD. Iversen LL, et al. Biochem Soc Trans. 1991 Nov;19(4):913-5. doi: 10.1042/bst0190913. Biochem Soc Trans. 1991. PMID: 1794582 Review. No abstract available.
• Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons.

  Kalindjian SB, Buck IM, Davies JM, Dunstone DJ, Hudson ML, Low CM, McDonald IM, Pether MJ, Steel KI, Tozer MJ, Vinter JG. Kalindjian SB, et al. J Med Chem. 1996 Apr 26;39(9):1806-15. doi: 10.1021/jm9508907. J Med Chem. 1996. PMID: 8627604
• Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.

  Ninomiya K, Saito T, Wakatsuki K, Saeki M, Kato T, Kasai H, Kimura K, Fujii M. Ninomiya K, et al. Arzneimittelforschung. 1998 Jan;48(1):52-4. Arzneimittelforschung. 1998. PMID: 9522032
• "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).

  Roche S, Gusdinar T, Bali JP, Magous R. Roche S, et al. Biochem Pharmacol. 1991 Jul 25;42(4):771-6. doi: 10.1016/0006-2952(91)90035-4. Biochem Pharmacol. 1991. PMID: 1714276
• Therapeutic potential of cholecystokinin receptor antagonists in CNS disorders.

  Schiantarelli P. Schiantarelli P. Pharmacol Res. 1993 Jul-Aug;28(1):1-9. doi: 10.1006/phrs.1993.1104. Pharmacol Res. 1993. PMID: 8234141 Review. No abstract available.